Loading
IARC estimates 4,205 new cancer cases and 2,520 cancer deaths in Namibia in 2024; the commonest new cancers are breast, cervix uteri and prostate. This page is assembled automatically from OnCo's data: 1 institution, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 701 | 59.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 453 | 37.2 | Cervical cancer |
| Prostate | 440 | 69.8 | Prostate cancer |
| Kaposi sarcoma | 334 | 12.7 | Kaposi sarcoma |
| Non-Hodgkin lymphoma | 167 | 7.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Colorectum | 164 | 8.3 | Colorectal cancer |
| Lip, oral cavity | 131 | 6.8 | |
| Trachea, bronchus and lung | 102 | 5.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Melanoma of skin | 90 | 4.9 | Melanoma |
| Liver and intrahepatic bile ducts | 78 | 3.8 | Hepatocellular carcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 396 | 34.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 293 | 24.5 | Cervical cancer |
| Prostate | 258 | 41.9 | Prostate cancer |
| Kaposi sarcoma | 131 | 5.1 | Kaposi sarcoma |
| Trachea, bronchus and lung | 99 | 5.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 89 | 4.8 | Colorectal cancer |
| Lip, oral cavity | 88 | 4.7 | |
| Non-Hodgkin lymphoma | 81 | 3.8 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Liver and intrahepatic bile ducts | 74 | 3.7 | Hepatocellular carcinoma |
| Leukaemia | 53 | 2.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
No trial record in OnCo lists a site in Namibia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Namibia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Namibia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.